APW
HAE icon

Aventura Private Wealth’s Haemonetics HAE Stock Holding History

Aventura Private Wealth’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13
Closed -$1.01K – 799
2024
Q4 		$1.01K Buy
+13
New +$1.04K ﹤0.01% 640

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Aventura Private Wealth's HAE Position: Q1 2025 in Review

Aventura Private Wealth sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 13 shares — an estimated $1.01K sold.

Aventura Private Wealth first reported a position in HAE in Q4 2024 and held it in 1 quarter. The position peaked at $1.01K in Q4 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Aventura Private Wealth reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 13 Haemonetics shares in Q1 2025, an estimated $1.01K.
  • Aventura Private Wealth first reported a position in Haemonetics in Q4 2024 and held it in 1 quarter.
  • Aventura Private Wealth's Haemonetics position peaked at $1.01K in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Aventura Private Wealth's 13F filing for Q1 2025, filed 7 Jan 2026.